Non-antibiotisk behandling af sepsis

K Møller, G Kronborg, B K Pedersen

Abstract

Treatment of patients with sepsis with monoclonal antibodies against lipopolysaccharide, tumour necrosis factor or treatment with soluble TNF-receptors or interleukin-1 receptor antagonist have not had any effect on mortality. Treatment with intravenous polyclonal nonspecific immunoglobulin has been shown to have beneficial efficacy on mortality. However, the number of patients included in the latter treatment studies are limited, the patients studied are heterogeneous and do not allow to conclude that sepsis patients should be routinely treated with immunoglobulins.

Bidragets oversatte titelNon-antibiotic treatment of sepsis
OriginalsprogDansk
TidsskriftUgeskrift for Laeger
Vol/bind162
Udgave nummer20
Sider (fra-til)2872-5
Antal sider4
ISSN0041-5782
StatusUdgivet - 15 maj 2000
Udgivet eksterntJa

Emneord

  • Animals
  • Antibodies, Monoclonal/therapeutic use
  • Clinical Trials as Topic
  • Humans
  • Immunoglobulins, Intravenous/therapeutic use
  • Interleukin-1/immunology
  • Receptors, Interleukin-1/antagonists & inhibitors
  • Receptors, Tumor Necrosis Factor/antagonists & inhibitors
  • Sepsis/drug therapy
  • Tumor Necrosis Factor-alpha/immunology

Fingeraftryk

Dyk ned i forskningsemnerne om 'Non-antibiotisk behandling af sepsis'. Sammen danner de et unikt fingeraftryk.

Citationsformater